Skip to main content
Midas Edge

CYBIN INC.

For the period ended Mar 31, 2026. Filed Jun 29, 2026.

View on SEC.gov

About this filing

The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.

FY2026 · Filed Jun 29, 2026

Use the contents to explore the available documents and sections.

HELP$8.96+6.8%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

EX-99.2 · Page 53 of

CYBIN INC. DOING BUSINESS AS HELUS PHARMA NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS March 31, 2026 and 2025 (All amounts expressed in thousands of U.S. dollars, except share and per share amounts, and those amounts indicated as being in CAD, Euros or Great Britain Pounds which are in thousands.)

losses have no expiry but are subject to limitations on utilization as laid out below. The Massachusetts non-capital losses expire as follows:

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.